UNIVERSITY OF WASHINGTON
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1861-01-01
- Employees
- 10K
- Market Cap
- -
Ceritinib With Brentuximab Vedotin in Treating Patients With ALK-Positive Anaplastic Large Cell Lymphoma
Phase 1
Withdrawn
- Conditions
- Anaplastic Large Cell Lymphoma, ALK-PositiveCD30-Positive Neoplastic Cells PresentSystemic Anaplastic Large Cell Lymphoma
- Interventions
- Other: Laboratory Biomarker AnalysisOther: Pharmacological Study
- First Posted Date
- 2016-04-06
- Last Posted Date
- 2019-10-10
- Lead Sponsor
- University of Washington
- Registration Number
- NCT02729961
- Locations
- 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Filgrastim, Cladribine, Cytarabine, and Mitoxantrone With Sorafenib in Treating Patients With Newly-Diagnosed, Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Phase 1
Completed
- Conditions
- Myelodysplastic SyndromeMyeloproliferative NeoplasmAcute Myeloid Leukemiade Novo Myelodysplastic SyndromeAcute Biphenotypic Leukemia
- Interventions
- Biological: FilgrastimOther: Laboratory Biomarker AnalysisOther: Quality-of-Life Assessment
- First Posted Date
- 2016-04-05
- Last Posted Date
- 2023-07-05
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 84
- Registration Number
- NCT02728050
- Locations
- 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Collaborative Perinatal Mental Health and Parenting Support in Primary Care
Not Applicable
Completed
- Conditions
- ParentingMother-child Relations
- Interventions
- Behavioral: Promoting First Relationships®
- First Posted Date
- 2016-03-31
- Last Posted Date
- 2021-12-15
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 252
- Registration Number
- NCT02724774
- Locations
- 🇺🇸
University of Washington, Seattle, Washington, United States
Apalutamide in Treating Patients With Prostate Cancer Who Are in Active Surveillance
Phase 2
Terminated
- Conditions
- Prostate Adenocarcinoma
- Interventions
- Other: Laboratory Biomarker AnalysisOther: Quality-of-Life AssessmentOther: Questionnaire Administration
- First Posted Date
- 2016-03-29
- Last Posted Date
- 2023-02-09
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 24
- Registration Number
- NCT02721979
- Locations
- 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Overcoming Barriers to HIV/AIDS Care and ART Initiation
Not Applicable
Completed
- Conditions
- Engagement in HIV Care
- Interventions
- Behavioral: Expedited CD4 testingBehavioral: Supplemental peer counseling
- First Posted Date
- 2016-03-24
- Last Posted Date
- 2019-03-13
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 315
- Registration Number
- NCT02718456
- Locations
- 🇰🇪
Karen Health Center, Nairobi, Kenya
Quantifying Patient-Specific Changes in Neuromuscular Control in Cerebral Palsy
Completed
- Conditions
- Cerebral Palsy
- Interventions
- Procedure: Single-event multilevel surgery
- First Posted Date
- 2016-03-04
- Last Posted Date
- 2022-05-09
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 55
- Registration Number
- NCT02699554
- Locations
- 🇺🇸
Gillette Children's Specialty Healthcare, Saint Paul, Minnesota, United States
Biological Determinants of Peritoneal Dialysis
Completed
- Conditions
- End-Stage Kidney Disease
- Interventions
- Other: Peritoneal Equilibrium TestOther: 4 hour dwell of 2.5/4.25% dextrose solution
- First Posted Date
- 2016-02-29
- Last Posted Date
- 2021-12-10
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 4865
- Registration Number
- NCT02694068
- Locations
- 🇺🇸
University of Washington, Seattle, Washington, United States
"Pharmacokinetic Study of Nicotinamide Riboside"
Phase 1
Completed
- Conditions
- Metabolic Disturbance
- Interventions
- Dietary Supplement: nicotinamide riboside
- First Posted Date
- 2016-02-24
- Last Posted Date
- 2018-02-08
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 8
- Registration Number
- NCT02689882
- Locations
- 🇺🇸
University of Washington, Seattle, Washington, United States
Incidence and Severity of Residual Neuromuscular Blockade
Phase 4
Completed
- Conditions
- Residual Neuromuscular Blockade
- Interventions
- Procedure: Standardized NMBD Management
- First Posted Date
- 2016-01-21
- Last Posted Date
- 2019-05-20
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 78
- Registration Number
- NCT02660398
- Locations
- 🇺🇸
University of Washington Medical Center, Seattle, Washington, United States
A Policy Relevant US Trauma Care System Pragmatic Trial for PTSD and Comorbidity
Not Applicable
Completed
- Conditions
- DepressionPosttraumatic Stress DisorderMild Cognitive ImpairmentAlcohol-Related DisordersSubstance-Related DisordersWounds and InjurySuicidal IdeationBrain InjuriesQuality of LifeChronic Disease
- Interventions
- Behavioral: Motivational InterviewingBehavioral: Cognitive Behavioral Therapy ElementsBehavioral: Care Management
- First Posted Date
- 2016-01-14
- Last Posted Date
- 2021-07-02
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 635
- Registration Number
- NCT02655354
- Locations
- 🇺🇸
Jacobi Medical Center, Bronx, New York, United States
🇺🇸University of Rochester, Rochester, New York, United States
🇺🇸Honor Health, Scottsdale, Arizona, United States
© Copyright 2025. All Rights Reserved by MedPath